Choice of antihypertensive drugs for the treatment of hypertension, including hypertensive emergencies.
D000959:Antihypertensive Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D001626:Bethanechol Compounds / Q000627:therapeutic use; D003000:Clonidine / Q000627:therapeutic use; D003981:Diazoxide / Q000627:therapeutic use; D004232:Diuretics / Q000627:therapeutic use; D004630:Emergencies; D005292:Ferricyanides / Q000627:therapeutic use; D005730:Ganglionic Blockers / Q000627:therapeutic use; D006145:Guanethidine / Q000627:therapeutic use; D006801:Humans; D006830:Hydralazine / Q000627:therapeutic use; D006973:Hypertension / Q000150:complications / Q000188:drug therapy*; D008750:Methyldopa / Q000627:therapeutic use; D008914:Minoxidil / Q000627:therapeutic use; D009130:Muscle, Smooth / Q000187:drug effects; D010293:Pargyline / Q000627:therapeutic use; D011433:Propranolol / Q000627:therapeutic use; D046948:Secologanin Tryptamine Alkaloids / Q000627:therapeutic use; D049993:Sodium Chloride Symporter Inhibitors / Q000627:therapeutic use; D014665:Vasodilator Agents / Q000494:pharmacology
D000959:Antihypertensive Agents; D001626:Bethanechol Compounds; D004232:Diuretics; D005292:Ferricyanides; D005730:Ganglionic Blockers; D046948:Secologanin Tryptamine Alkaloids; D049993:Sodium Chloride Symporter Inhibitors; D014665:Vasodilator Agents; D006830:Hydralazine; D008750:Methyldopa; D008914:Minoxidil; D010293:Pargyline; D011433:Propranolol; D003000:Clonidine; D003981:Diazoxide; D006145:Guanethidine